Intravenous Erythropoietin in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the REVEAL Randomized Controlled Trial

CONTEXT: Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function. OBJECTIVE: To evaluate the safety and efficacy of a single intravenous bolus...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Najjar, Samer S., Rao, Sunil V., Melloni, Chiara, Raman, Subha V., Povsic, Thomas J., Melton, Laura, Barsness, Gregory W., Prather, Kristi, Heitner, John F., Kilaru, Rakhi, Gruberg, Luis, Hasselblad, Vic, Greenbaum, Adam B., Patel, Manesh, Kim, Raymond J., Talan, Mark, Ferrucci, Luigi, Longo, Dan L., Lakatta, Edward G., Harrington, Robert A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486644/
https://ncbi.nlm.nih.gov/pubmed/21558517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados